403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Avant Technologies Inc
(MENAFN- Baystreet) 02:17 PM EST - Avant Technologies Inc: Announced that its 50/50 joint venture with Austrianova has entered into an exclusive, worldwide License Agreement with Klothea Bio, Inc. The license agreement, effective immediately, grants Klothonova exclusive global rights to develop, manufacture, and commercialize Klothea Bio's proprietary Klotho producing cells, encapsulated using Austrianova's proprietary Cell-in-a-Box® technology, for the treatment of diseases and conditions in humans and animals. Avant Technologies Inc
shares O are trading off $0.03 at $0.32.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment